975 Cornforth Drive
Kent Science Park
Sittingbourne, Kent ME9 8PX
T 01795 437426
F 01795 423440
E info@irpharma.co.uk
Kent Science Park
Sittingbourne, Kent ME9 8PX
T 01795 437426
F 01795 423440
E info@irpharma.co.uk
National Heart & Lung Institute
Sir Alexander Fleming Building
Imperial College, London SW7 2AZ
T 01795 437426
F 01795 423440
E info@irpharma.co.uk
Sir Alexander Fleming Building
Imperial College, London SW7 2AZ
T 01795 437426
F 01795 423440
E info@irpharma.co.uk
Technology Overview - The drug development process at IRP
IRP can provide a range of models and tests that together provide a comprehensive process for evaluation of respiratory drugs. The process essentially comprises four key stages, which represents current best practise in respiratory drug evaluation and encompasses:
- target validation
- in vitro profiling
- in vivo profiling
- pharmacological assessment of key biomarkers
In addition to methods for investigating parameters within normal tissue, IR Pharma has developed respiratory disease models tailored to evaluate drug efficacy in;
- Asthma
- COPD
We believe this combination of assays and models provides a front line capability for those companies wishing to gain insight into effects and efficacy of drug candidates at the pre-clinical stage.